UK vs. ISPC, LICN, APDN, AUUD, LYT, DKDCA, HAO, SYRA, SRAX, and MULN
Should you be buying Ucommune International stock or one of its competitors? The main competitors of Ucommune International include iSpecimen (ISPC), Lichen International (LICN), Applied DNA Sciences (APDN), Auddia (AUUD), Lytus Technologies Holdings PTV. (LYT), Data Knights Acquisition (DKDCA), Haoxi Health Technology (HAO), Syra Health (SYRA), SRAX (SRAX), and Mullen Automotive (MULN). These companies are all part of the "business services" industry.
Ucommune International vs. Its Competitors
iSpecimen (NASDAQ:ISPC) and Ucommune International (NASDAQ:UK) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.
Ucommune International has a net margin of 0.00% compared to iSpecimen's net margin of -139.63%. Ucommune International's return on equity of 0.00% beat iSpecimen's return on equity.
13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 36.9% of Ucommune International shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Comparatively, 14.2% of Ucommune International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
iSpecimen has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Ucommune International has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Ucommune International has higher revenue and earnings than iSpecimen.
In the previous week, iSpecimen had 1 more articles in the media than Ucommune International. MarketBeat recorded 1 mentions for iSpecimen and 0 mentions for Ucommune International. Ucommune International's average media sentiment score of 0.00 beat iSpecimen's score of -0.36 indicating that Ucommune International is being referred to more favorably in the news media.
Summary
Ucommune International beats iSpecimen on 8 of the 11 factors compared between the two stocks.
Get Ucommune International News Delivered to You Automatically
Sign up to receive the latest news and ratings for UK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding UK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ucommune International Competitors List
Related Companies and Tools
This page (NASDAQ:UK) was last updated on 7/4/2025 by MarketBeat.com Staff
Free UK Stock Alerts